Latham & Watkins Adds Two Leading Patent Litigators

Michael Morin and David Frazier join the firm’s Washington, D.C. office, adding two experienced trial lawyers to its world-class IP practice.

February 2, 2015

Washington, D.C.…Latham & Watkins LLP1 is pleased to announce that Michael Morin and David Frazier, Ph.D. have joined the firm’s Washington, D.C. office as partners in the Litigation Department. Both are seasoned patent litigators, with particular experience in pharmaceutical and biologics cases, and they have handled cases involving some of the world’s best-selling drugs.

Morin litigates high-stakes patent disputes in a variety of subject matters, including in the biotechnology and pharmaceutical arena, as well as in the software, consumer goods, medical device, video game, sporting goods and mechanical equipment areas. He has been lead counsel in many high-stakes cases, and has first-chaired numerous trials and arbitrations. Morin has an active appellate practice, and has argued six times before the U.S. Court of Appeals for the Federal Circuit.

Frazier focuses primarily on branded pharmaceutical and biologics patent litigation, handling both brand-on-brand and Hatch-Waxman cases. He has a long track record of developing effective litigation strategies for clients by combining a deep understanding of complex technology with extensive experience in pharmaceutical patent litigation. Frazier also regularly advises clients on IP-related issues outside the litigation context.

Matthew Moore, a Washington, D.C. partner and Global Co-Chair of the firm’s Intellectual Property Litigation Practice Group, said: “We are thrilled to welcome Mike and David to our team. In addition to being great people, Mike and David are exactly the type of experienced, first-chair trial lawyers that we have been strategically adding to our team in Washington, D.C., Chicago, Northern California and New York over the last four years.”

“In addition to their other, broad-based IP litigation experience, Mike and David are highly experienced with pharmaceutical and biologics technologies and related patents or cases concerning them. We are delighted to welcome them both to Latham and to add their technical backgrounds and exceptional trial skills to our growing patent litigation practice in the pharmaceutical arena, and particularly in biotechnology, where such work is poised to expand significantly,” added Chicago partner and Global Co-Chair of the firm’s Intellectual Property Litigation Practice Group Kenneth Schuler.

Alice Fisher, Office Managing Partner of the firm’s Washington, D.C. office said: “We could not be happier to welcome Mike and David to the firm. Both boast excellent track records, and they join a talented bench of lawyers in the Washington, D.C. office who are dedicated to helping clients address their most complex business and legal challenges.”

“David and I are excited to be joining Latham & Watkins, a firm with an exceptional global platform and trial resources. We were particularly attracted to the strategic and collegial approach that the firm’s IP practice has taken to build a premier trial practice, and we look forward to contributing to that teamwork and success,” said Morin.

“In this highly competitive marketplace the stakes for clients are truly bet-the-company. I am thrilled to be joining, along with Mike, an integrated, talented group of partners. We look forward to continuing to build our practices with this team of experienced litigators,” said Frazier.

Morin and Frazier join the firm from Finnegan, Henderson, Farabow, Garrett & Dunner, LLP in Washington, D.C. Morin received his J.D., with honors, Order of the Coif, from the George Washington University National Law Center and a B.S. in Industrial Engineering from Purdue University. Frazier received his J.D., magna cum laude, Order of the Coif, from the Georgetown University Law Center; a Ph.D. in Microbiology and Molecular Genetics from Harvard University; and a B.S. in Molecular and Cell Biology, with honors, from the Pennsylvania State University.

About Latham & Watkins


Latham & Watkins is a global law firm with approximately 2,100 lawyers in its offices located in Asia, Europe, the Middle East and the United States, including: Abu Dhabi, Barcelona, Beijing, Boston, Brussels, Century City, Chicago, Doha, Dubai, Düsseldorf, Frankfurt, Hamburg, Hong Kong, Houston, London, Los Angeles, Madrid, Milan, Moscow, Munich, New Jersey, New York, Orange County, Paris, Riyadh, Rome, San Diego, San Francisco, Shanghai, Silicon Valley, Singapore, Tokyo and Washington, D.C. For more information on Latham & Watkins, please visit the website at www.lw.com.

Notes to Editors


1 Latham & Watkins operates as a limited liability partnership worldwide with affiliated limited liability partnerships conducting the practice in the United Kingdom, France and Italy and affiliated partnerships conducting the practice in Hong Kong, Japan and Singapore. Latham & Watkins practices in Saudi Arabia in association with the Law Office of Salman M. Al-Sudairi.

Contacts


Alice Fisher, Office Managing Partner, Washington, D.C., 555 Eleventh Street, NW, Suite 1000, Washington, D.C. 20004-1304, +1.202.637.2232

Matthew Moore, Global Co-Chair of the Intellectual Property Litigation Practice Group, 555 Eleventh Street, NW, Suite 1000, Washington, D.C. 20004-1304, +1.202.637.2278

Kenneth Schuler, Global Co-Chair of the Intellectual Property Litigation Practice Group, 330 North Wabash Avenue, Suite 2800, Chicago, IL 60611, +1.312.876.7659

 
 
Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.